Clinical trials for Cancer in United States

Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer

Study ID: NCT05294302

Sponsor

Nemours Children's Clinic

Intraoperative Tumor Margin Identification With ICG Dye Imaging

Study ID: NCT04752137

Sponsor

Massachusetts General Hospital

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

Study ID: NCT06940739

Sponsor

Iovance Biotherapeutics, Inc.

Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study

Study ID: NCT05524428

Sponsor

Massachusetts General Hospital

The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy

Study ID: NCT06318507

Sponsor

Pennington Biomedical Research Center

Know and Own Your Movement-related Metrics Via Wearable Devices

Study ID: NCT05490641

Sponsor

The University of Texas at Arlington

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Study ID: NCT06514794

Sponsor

Wugen, Inc.

Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer

Study ID: NCT05922930

Sponsor

M.D. Anderson Cancer Center

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

Study ID: NCT06103864

Sponsor

AstraZeneca

Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant

Study ID: NCT05839119

Sponsor

Brown University